In chronic inflammatory processes such as atherosclerosis, endothelial‐retargeted AAV9‐transduction of anti‐inflammatory Anxa1 attenuates aortic recruitment of neutrophils [25] and monocytes in atherosclerotic plaques 2 months after transduction. This evidence concerns the gene ANXA1 and atherosclerosis.